Literature DB >> 25224324

POLE mutations as an alternative pathway for microsatellite instability in endometrial cancer: implications for Lynch syndrome testing.

Panagiotis A Konstantinopoulos1, Ursula A Matulonis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25224324     DOI： 10.1002/cncr.29057

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  Regression of Chemotherapy-Resistant Polymerase ε (POLE) Ultra-Mutated and MSH6 Hyper-Mutated Endometrial Tumors with Nivolumab.

Authors:  Alessandro D Santin; Stefania Bellone; Natalia Buza; Jungmin Choi; Peter E Schwartz; Joseph Schlessinger; Richard P Lifton
Journal:  Clin Cancer Res       Date:  2016-08-02       Impact factor: 12.531

2.  Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro.

Authors:  Stefania Bellone; Eliana Bignotti; Silvia Lonardi; Francesca Ferrari; Floriana Centritto; Alice Masserdotti; Francesca Pettinella; Jonathan Black; Gulden Menderes; Gary Altwerger; Pei Hui; Salvatore Lopez; Christopher de Haydu; Elena Bonazzoli; Federica Predolini; Luca Zammataro; Emiliano Cocco; Federico Ferrari; Antonella Ravaggi; Chiara Romani; Fabio Facchetti; Enrico Sartori; Franco E Odicino; Dan-Arin Silasi; Babak Litkouhi; Elena Ratner; Masoud Azodi; Peter E Schwartz; Alessandro D Santin
Journal:  Gynecol Oncol       Date:  2016-11-26       Impact factor: 5.482

Review 3.  Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma.

Authors:  Jinru Shia
Journal:  Semin Diagn Pathol       Date:  2015-02-04       Impact factor: 3.464

Review 4.  Important molecular genetic markers of colorectal cancer.

Authors:  Anna V Kudryavtseva; Anastasia V Lipatova; Andrew R Zaretsky; Alexey A Moskalev; Maria S Fedorova; Anastasiya S Rasskazova; Galina A Shibukhova; Anastasiya V Snezhkina; Andrey D Kaprin; Boris Y Alekseev; Alexey A Dmitriev; George S Krasnov
Journal:  Oncotarget       Date:  2016-08-16

5.  POLE-mutated clear cell cervical cancer associated with in-utero diethylstilbestrol exposure.

Authors:  Elizabeth K Lee; Neal I Lindeman; Ursula A Matulonis; Panagiotis A Konstantinopoulos
Journal:  Gynecol Oncol Rep       Date:  2019-01-29

6.  PD-L1 and CD4 are independent prognostic factors for overall survival in endometrial carcinomas.

Authors:  Shuang Zhang; Takeo Minaguchi; Chenyang Xu; Nan Qi; Hiroya Itagaki; Ayumi Shikama; Nobutaka Tasaka; Azusa Akiyama; Manabu Sakurai; Hiroyuki Ochi; Toyomi Satoh
Journal:  BMC Cancer       Date:  2020-02-17       Impact factor: 4.430

7.  Long-term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancer.

Authors:  N Ari Wijetunga; Carlos H Dos Anjos; W Iris Zhi; Mark Robson; C Jillian Tsai; Yoshiya Yamada; Laura Dover; Erin F Gillespie; Amy J Xu; Jonathan T Yang
Journal:  Cancer Med       Date:  2021-06-22       Impact factor: 4.452
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.